Rochel Daphné, Burger Myriam, Nguyen Patrick, Jaillardon Laetitia
1 Oniris, Department of Biology, Pathology and Food Sciences, Nantes Atlantic College of Veterinary Medicine, Food Science and Engineering, Nantes, France.
2 University of Nantes Angers, Nantes, France.
J Feline Med Surg. 2018 Feb;20(2):179-183. doi: 10.1177/1098612X17694735. Epub 2017 Feb 1.
Objectives The aim of this study was to evaluate changes in circulating insulin-like growth factor type 1 (IGF-1) concentrations in hyperthyroid cats, before and after thiamazole treatment. Methods Thirty-four hyperthyroid cats were retrospectively included. Plasma free thyroxine (fT4) and IGF-1 concentrations were measured at diagnosis and 3 months after initiating antithyroid drug therapy. Results Median fT4 significantly decreased ( P <0.001) after treatment (from 78 pmol/l [range 43-122 pmol/l] to 31 pmol/l [range below assay limit of detection to 88 pmol/l]), whereas IGF-1 values significantly increased ( P <0.001) after treatment (from 117 ng/ml [33-341 ng/ml] to 221 ng/ml [36-865 ng/ml]). fT4 and IGF-1 concentrations were significantly negatively correlated both at diagnosis (r = -0.43, P = 0.01) and after treatment (r = -0.51, P = 0.002). Conclusions and relevance In cats, IGF-1 concentrations appear to be inversely proportional to the severity of hyperthyroidism and significantly increase after treatment with thiamazole.
目的 本研究旨在评估甲巯咪唑治疗前后甲状腺功能亢进猫循环中胰岛素样生长因子1(IGF-1)浓度的变化。方法 回顾性纳入34只甲状腺功能亢进猫。在诊断时及开始抗甲状腺药物治疗3个月后测定血浆游离甲状腺素(fT4)和IGF-1浓度。结果 治疗后fT4中位数显著降低(P<0.001)(从78 pmol/l[范围43 - 122 pmol/l]降至31 pmol/l[范围低于检测下限至88 pmol/l]),而IGF-1值在治疗后显著升高(P<0.001)(从117 ng/ml[33 - 341 ng/ml]升至221 ng/ml[36 - 865 ng/ml])。fT4和IGF-1浓度在诊断时(r = -0.43,P = 0.01)和治疗后(r = -0.51,P = 0.002)均呈显著负相关。结论及相关性 在猫中,IGF-1浓度似乎与甲状腺功能亢进的严重程度成反比,且在甲巯咪唑治疗后显著升高。